Ironwood Pharmaceuticals
IRWD
#6947
Rank
C$0.78 B
Marketcap
C$4.81
Share price
-6.70%
Change (1 day)
-0.93%
Change (1 year)

Earnings for Ironwood Pharmaceuticals (IRWD)

Earnings in 2025 (TTM): C$0.12 Billion

According to Ironwood Pharmaceuticals 's latest financial reports the company's current earnings are C$0.33 Billion. In 2024 the company made an earning of C$90.07 Million, an increase over its 2023 earnings that were of -C$1.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ironwood Pharmaceuticals from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$0.12 B42.55%
2024 C$90.07 M-106.88%
2023 -C$1.31 Billion-475.59%
2022 C$0.34 B25.8%
2021 C$0.27 B84.32%
2020 C$0.15 B84.69%
2019 C$81.42 M-125.13%
2018 -C$0.33 Billion100.62%
2017 -C$0.17 Billion43.12%
2016 -C$0.12 Billion-42.73%
2015 -C$0.2 Billion-24.76%
2014 -C$0.27 Billion-30.49%
2013 -C$0.38 Billion275.65%
2012 -C$0.11 Billion11.56%
2011 -C$89.94 Million9.38%
2010 -C$82.22 Million-15.21%
2009 -C$96.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nektar Therapeutics
NKTR
-C$0.16 Billion-221.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$18.08 B 13,890.27%๐Ÿ‡ฌ๐Ÿ‡ง UK